推动创新药械走向临床“最后一公里”

Core Viewpoint - The article emphasizes the need for improved access and integration of innovative medical devices and AI technologies in clinical settings, particularly for newborns and prenatal diagnostics, to enhance healthcare outcomes in China [1][2][4]. Group 1: AI in Prenatal Diagnosis - The accuracy of prenatal diagnosis for congenital defects currently ranges from 30% to 60%, highlighting a significant gap in early detection capabilities [2]. - AI technology is seen as a promising solution to enhance the accuracy and accessibility of prenatal diagnostics by training models on extensive ultrasound data to identify key diagnostic features [2][3]. - There is a proposal to establish targeted funding for AI innovations in maternal and child health to overcome existing technical barriers in prenatal diagnostics [3]. Group 2: Challenges in Clinical Application - Despite advancements in minimally invasive surgical techniques for newborns, such as thoracoscopic surgery for esophageal atresia, there are challenges in bringing these innovations to clinical practice due to complex regulatory pathways [4]. - The article discusses the need for a cross-disciplinary expert advisory committee to provide clear guidance on the clinical translation of innovative products that combine medical devices and biological agents [4]. - Many high-performance domestic medical devices are not included in procurement lists due to difficulties in meeting standard procurement volume and pricing requirements, limiting their availability in hospitals [4][5]. Group 3: Policy Recommendations - It is recommended to create a more flexible access and procurement channel for innovative domestic medical devices that address urgent clinical needs, particularly for vulnerable populations like newborns [5].